Celiac Disease Drug Market Size, Share, Growth, and Industry Analysis, By Type (Distension, Diarrhea, Anorexia, Others), By Application (First Line of Treatment, Second Line of Treatment), Regional Insights and Forecast to 2035
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Celiac Disease Drug Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Celiac Disease Drug Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Celiac Disease Drug Business Mode and Production Process
2.3.1 Celiac Disease Drug Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Celiac Disease Drug Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Celiac Disease Drug
2.4.2 Raw Material Cost of Celiac Disease Drug
2.4.3 Labor Cost of Celiac Disease Drug
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Celiac Disease Drug Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Celiac Disease Drug Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Celiac Disease Drug Price by Manufacturer (2021-2026)
4.4 Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Celiac Disease Drug, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Celiac Disease Drug, Product Offered and Application
4.7 Celiac Disease Drug Market Competitive Situation and Trends
4.7.1 Celiac Disease Drug Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Celiac Disease Drug Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Celiac Disease Drug Market Historical Development by Geographic Region (2021-2026)
5.1 Global Celiac Disease Drug Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Celiac Disease Drug Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Celiac Disease Drug Market Status by Country (2021-2026)
5.3.1 North America Celiac Disease Drug Sales Volume by Country (2021-2026)
5.3.2 North America Celiac Disease Drug Revenue by Country (2021-2026)
5.3.3 United States Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Celiac Disease Drug Market Status by Country (2021-2026)
5.4.1 Europe Celiac Disease Drug Sales Volume by Country (2021-2026)
5.4.2 Europe Celiac Disease Drug Revenue by Country (2021-2026)
5.4.3 Germany Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Celiac Disease Drug Market Status by Country (2021-2026)
5.5.1 Asia Pacific Celiac Disease Drug Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Celiac Disease Drug Revenue by Country (2021-2026)
5.5.3 China Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Celiac Disease Drug Market Status by Country (2021-2026)
5.6.1 Latin America Celiac Disease Drug Sales Volume by Country (2021-2026)
5.6.2 Latin America Celiac Disease Drug Revenue by Country (2021-2026)
5.6.3 Mexico Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Celiac Disease Drug Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Celiac Disease Drug Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Celiac Disease Drug Revenue by Country (2021-2026)
5.7.3 GCC Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
6 Global Celiac Disease Drug Market Historical Development by Product Type (2021-2026)
6.1 Celiac Disease Drug Definition by Type
6.2 Global Celiac Disease Drug Historical Sales Volume by Product Type (2021-2026)
6.3 Global Celiac Disease Drug Historical Revenue by Product Type (2021-2026)
6.4 Global Celiac Disease Drug Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Distension (2021-2026)
6.5.2 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Diarrhea (2021-2026)
6.5.3 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Anorexia (2021-2026)
6.5.4 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
7 Global Celiac Disease Drug Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Celiac Disease Drug Historical Sales Volume by End User (2021-2026)
7.3 Global Celiac Disease Drug Historical Revenue by End User (2021-2026)
7.4 Global Celiac Disease Drug Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of First Line of Treatment (2021-2026)
7.5.2 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Second Line of Treatment (2021-2026)
8 Leading Companies Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Corporation Information
8.1.2 Johnson & Johnson - Celiac Disease Drug Product Portfolio and Specification
8.1.3 Johnson & Johnson Performance Analysis (2021-2026)
8.1.4 Johnson & Johnson Business and Markets Served
8.1.5 Johnson & Johnson Recent Developments
8.2 Anthera Pharmaceuticals
8.2.1 Anthera Pharmaceuticals Corporation Information
8.2.2 Anthera Pharmaceuticals - Celiac Disease Drug Product Portfolio and Specification
8.2.3 Anthera Pharmaceuticals Performance Analysis (2021-2026)
8.2.4 Anthera Pharmaceuticals Business and Markets Served
8.2.5 Anthera Pharmaceuticals Recent Developments
8.3 Biotest
8.3.1 Biotest Corporation Information
8.3.2 Biotest - Celiac Disease Drug Product Portfolio and Specification
8.3.3 Biotest Performance Analysis (2021-2026)
8.3.4 Biotest Business and Markets Served
8.3.5 Biotest Recent Developments
8.4 Amgen
8.4.1 Amgen Corporation Information
8.4.2 Amgen - Celiac Disease Drug Product Portfolio and Specification
8.4.3 Amgen Performance Analysis (2021-2026)
8.4.4 Amgen Business and Markets Served
8.4.5 Amgen Recent Developments
8.5 Biogen
8.5.1 Biogen Corporation Information
8.5.2 Biogen - Celiac Disease Drug Product Portfolio and Specification
8.5.3 Biogen Performance Analysis (2021-2026)
8.5.4 Biogen Business and Markets Served
8.5.5 Biogen Recent Developments
8.6 Bristol-Myers Squibb
8.6.1 Bristol-Myers Squibb Corporation Information
8.6.2 Bristol-Myers Squibb - Celiac Disease Drug Product Portfolio and Specification
8.6.3 Bristol-Myers Squibb Performance Analysis (2021-2026)
8.6.4 Bristol-Myers Squibb Business and Markets Served
8.6.5 Bristol-Myers Squibb Recent Developments
8.7 BioLineRx
8.7.1 BioLineRx Corporation Information
8.7.2 BioLineRx - Celiac Disease Drug Product Portfolio and Specification
8.7.3 BioLineRx Performance Analysis (2021-2026)
8.7.4 BioLineRx Business and Markets Served
8.7.5 BioLineRx Recent Developments
8.8 Merck
8.8.1 Merck Corporation Information
8.8.2 Merck - Celiac Disease Drug Product Portfolio and Specification
8.8.3 Merck Performance Analysis (2021-2026)
8.8.4 Merck Business and Markets Served
8.8.5 Merck Recent Developments
8.9 LFB Group
8.9.1 LFB Group Corporation Information
8.9.2 LFB Group - Celiac Disease Drug Product Portfolio and Specification
8.9.3 LFB Group Performance Analysis (2021-2026)
8.9.4 LFB Group Business and Markets Served
8.9.5 LFB Group Recent Developments
8.10 Novartis
8.10.1 Novartis Corporation Information
8.10.2 Novartis - Celiac Disease Drug Product Portfolio and Specification
8.10.3 Novartis Performance Analysis (2021-2026)
8.10.4 Novartis Business and Markets Served
8.10.5 Novartis Recent Developments
8.11 Takeda Pharmaceutical
8.11.1 Takeda Pharmaceutical Corporation Information
8.11.2 Takeda Pharmaceutical - Celiac Disease Drug Product Portfolio and Specification
8.11.3 Takeda Pharmaceutical Performance Analysis (2021-2026)
8.11.4 Takeda Pharmaceutical Business and Markets Served
8.11.5 Takeda Pharmaceutical Recent Developments
8.12 Pfizer
8.12.1 Pfizer Corporation Information
8.12.2 Pfizer - Celiac Disease Drug Product Portfolio and Specification
8.12.3 Pfizer Performance Analysis (2021-2026)
8.12.4 Pfizer Business and Markets Served
8.12.5 Pfizer Recent Developments
8.13 Bayer
8.13.1 Bayer Corporation Information
8.13.2 Bayer - Celiac Disease Drug Product Portfolio and Specification
8.13.3 Bayer Performance Analysis (2021-2026)
8.13.4 Bayer Business and Markets Served
8.13.5 Bayer Recent Developments
8.14 ADMA Biologics
8.14.1 ADMA Biologics Corporation Information
8.14.2 ADMA Biologics - Celiac Disease Drug Product Portfolio and Specification
8.14.3 ADMA Biologics Performance Analysis (2021-2026)
8.14.4 ADMA Biologics Business and Markets Served
8.14.5 ADMA Biologics Recent Developments
8.15 F. Hoffmann-La Roche
8.15.1 F. Hoffmann-La Roche Corporation Information
8.15.2 F. Hoffmann-La Roche - Celiac Disease Drug Product Portfolio and Specification
8.15.3 F. Hoffmann-La Roche Performance Analysis (2021-2026)
8.15.4 F. Hoffmann-La Roche Business and Markets Served
8.15.5 F. Hoffmann-La Roche Recent Developments
8.16 Kedrion Biopharma
8.16.1 Kedrion Biopharma Corporation Information
8.16.2 Kedrion Biopharma - Celiac Disease Drug Product Portfolio and Specification
8.16.3 Kedrion Biopharma Performance Analysis (2021-2026)
8.16.4 Kedrion Biopharma Business and Markets Served
8.16.5 Kedrion Biopharma Recent Developments
8.17 Celgene
8.17.1 Celgene Corporation Information
8.17.2 Celgene - Celiac Disease Drug Product Portfolio and Specification
8.17.3 Celgene Performance Analysis (2021-2026)
8.17.4 Celgene Business and Markets Served
8.17.5 Celgene Recent Developments
9 Global Celiac Disease Drug Market Forecast by Product Type and End User (2026-2034)
9.1 Global Celiac Disease Drug Market Forecast by Product Type (2026-2034)
9.1.1 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Distension (2026-2034)
9.1.2 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Diarrhea (2026-2034)
9.1.3 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Anorexia (2026-2034)
9.1.4 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Celiac Disease Drug Market Forecast by End User (2026-2034)
9.2.1 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of First Line of Treatment (2026-2034)
9.2.2 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Second Line of Treatment (2026-2034)
10 Global Celiac Disease Drug Market Forecast by Geographic Region (2026-2034)
10.1 Global Celiac Disease Drug Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Celiac Disease Drug Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Celiac Disease Drug Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Celiac Disease Drug Business Mode and Production Process
2.3.1 Celiac Disease Drug Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Celiac Disease Drug Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Celiac Disease Drug
2.4.2 Raw Material Cost of Celiac Disease Drug
2.4.3 Labor Cost of Celiac Disease Drug
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Celiac Disease Drug Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Celiac Disease Drug Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Celiac Disease Drug Price by Manufacturer (2021-2026)
4.4 Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Celiac Disease Drug, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Celiac Disease Drug, Product Offered and Application
4.7 Celiac Disease Drug Market Competitive Situation and Trends
4.7.1 Celiac Disease Drug Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Celiac Disease Drug Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Celiac Disease Drug Market Historical Development by Geographic Region (2021-2026)
5.1 Global Celiac Disease Drug Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Celiac Disease Drug Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Celiac Disease Drug Market Status by Country (2021-2026)
5.3.1 North America Celiac Disease Drug Sales Volume by Country (2021-2026)
5.3.2 North America Celiac Disease Drug Revenue by Country (2021-2026)
5.3.3 United States Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Celiac Disease Drug Market Status by Country (2021-2026)
5.4.1 Europe Celiac Disease Drug Sales Volume by Country (2021-2026)
5.4.2 Europe Celiac Disease Drug Revenue by Country (2021-2026)
5.4.3 Germany Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Celiac Disease Drug Market Status by Country (2021-2026)
5.5.1 Asia Pacific Celiac Disease Drug Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Celiac Disease Drug Revenue by Country (2021-2026)
5.5.3 China Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Celiac Disease Drug Market Status by Country (2021-2026)
5.6.1 Latin America Celiac Disease Drug Sales Volume by Country (2021-2026)
5.6.2 Latin America Celiac Disease Drug Revenue by Country (2021-2026)
5.6.3 Mexico Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Celiac Disease Drug Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Celiac Disease Drug Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Celiac Disease Drug Revenue by Country (2021-2026)
5.7.3 GCC Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Celiac Disease Drug Sales Volume, Revenue and Growth (2021-2026)
6 Global Celiac Disease Drug Market Historical Development by Product Type (2021-2026)
6.1 Celiac Disease Drug Definition by Type
6.2 Global Celiac Disease Drug Historical Sales Volume by Product Type (2021-2026)
6.3 Global Celiac Disease Drug Historical Revenue by Product Type (2021-2026)
6.4 Global Celiac Disease Drug Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Distension (2021-2026)
6.5.2 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Diarrhea (2021-2026)
6.5.3 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Anorexia (2021-2026)
6.5.4 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
7 Global Celiac Disease Drug Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Celiac Disease Drug Historical Sales Volume by End User (2021-2026)
7.3 Global Celiac Disease Drug Historical Revenue by End User (2021-2026)
7.4 Global Celiac Disease Drug Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of First Line of Treatment (2021-2026)
7.5.2 Global Celiac Disease Drug Historical Sales Volume, Revenue and Growth Rate of Second Line of Treatment (2021-2026)
8 Leading Companies Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Corporation Information
8.1.2 Johnson & Johnson - Celiac Disease Drug Product Portfolio and Specification
8.1.3 Johnson & Johnson Performance Analysis (2021-2026)
8.1.4 Johnson & Johnson Business and Markets Served
8.1.5 Johnson & Johnson Recent Developments
8.2 Anthera Pharmaceuticals
8.2.1 Anthera Pharmaceuticals Corporation Information
8.2.2 Anthera Pharmaceuticals - Celiac Disease Drug Product Portfolio and Specification
8.2.3 Anthera Pharmaceuticals Performance Analysis (2021-2026)
8.2.4 Anthera Pharmaceuticals Business and Markets Served
8.2.5 Anthera Pharmaceuticals Recent Developments
8.3 Biotest
8.3.1 Biotest Corporation Information
8.3.2 Biotest - Celiac Disease Drug Product Portfolio and Specification
8.3.3 Biotest Performance Analysis (2021-2026)
8.3.4 Biotest Business and Markets Served
8.3.5 Biotest Recent Developments
8.4 Amgen
8.4.1 Amgen Corporation Information
8.4.2 Amgen - Celiac Disease Drug Product Portfolio and Specification
8.4.3 Amgen Performance Analysis (2021-2026)
8.4.4 Amgen Business and Markets Served
8.4.5 Amgen Recent Developments
8.5 Biogen
8.5.1 Biogen Corporation Information
8.5.2 Biogen - Celiac Disease Drug Product Portfolio and Specification
8.5.3 Biogen Performance Analysis (2021-2026)
8.5.4 Biogen Business and Markets Served
8.5.5 Biogen Recent Developments
8.6 Bristol-Myers Squibb
8.6.1 Bristol-Myers Squibb Corporation Information
8.6.2 Bristol-Myers Squibb - Celiac Disease Drug Product Portfolio and Specification
8.6.3 Bristol-Myers Squibb Performance Analysis (2021-2026)
8.6.4 Bristol-Myers Squibb Business and Markets Served
8.6.5 Bristol-Myers Squibb Recent Developments
8.7 BioLineRx
8.7.1 BioLineRx Corporation Information
8.7.2 BioLineRx - Celiac Disease Drug Product Portfolio and Specification
8.7.3 BioLineRx Performance Analysis (2021-2026)
8.7.4 BioLineRx Business and Markets Served
8.7.5 BioLineRx Recent Developments
8.8 Merck
8.8.1 Merck Corporation Information
8.8.2 Merck - Celiac Disease Drug Product Portfolio and Specification
8.8.3 Merck Performance Analysis (2021-2026)
8.8.4 Merck Business and Markets Served
8.8.5 Merck Recent Developments
8.9 LFB Group
8.9.1 LFB Group Corporation Information
8.9.2 LFB Group - Celiac Disease Drug Product Portfolio and Specification
8.9.3 LFB Group Performance Analysis (2021-2026)
8.9.4 LFB Group Business and Markets Served
8.9.5 LFB Group Recent Developments
8.10 Novartis
8.10.1 Novartis Corporation Information
8.10.2 Novartis - Celiac Disease Drug Product Portfolio and Specification
8.10.3 Novartis Performance Analysis (2021-2026)
8.10.4 Novartis Business and Markets Served
8.10.5 Novartis Recent Developments
8.11 Takeda Pharmaceutical
8.11.1 Takeda Pharmaceutical Corporation Information
8.11.2 Takeda Pharmaceutical - Celiac Disease Drug Product Portfolio and Specification
8.11.3 Takeda Pharmaceutical Performance Analysis (2021-2026)
8.11.4 Takeda Pharmaceutical Business and Markets Served
8.11.5 Takeda Pharmaceutical Recent Developments
8.12 Pfizer
8.12.1 Pfizer Corporation Information
8.12.2 Pfizer - Celiac Disease Drug Product Portfolio and Specification
8.12.3 Pfizer Performance Analysis (2021-2026)
8.12.4 Pfizer Business and Markets Served
8.12.5 Pfizer Recent Developments
8.13 Bayer
8.13.1 Bayer Corporation Information
8.13.2 Bayer - Celiac Disease Drug Product Portfolio and Specification
8.13.3 Bayer Performance Analysis (2021-2026)
8.13.4 Bayer Business and Markets Served
8.13.5 Bayer Recent Developments
8.14 ADMA Biologics
8.14.1 ADMA Biologics Corporation Information
8.14.2 ADMA Biologics - Celiac Disease Drug Product Portfolio and Specification
8.14.3 ADMA Biologics Performance Analysis (2021-2026)
8.14.4 ADMA Biologics Business and Markets Served
8.14.5 ADMA Biologics Recent Developments
8.15 F. Hoffmann-La Roche
8.15.1 F. Hoffmann-La Roche Corporation Information
8.15.2 F. Hoffmann-La Roche - Celiac Disease Drug Product Portfolio and Specification
8.15.3 F. Hoffmann-La Roche Performance Analysis (2021-2026)
8.15.4 F. Hoffmann-La Roche Business and Markets Served
8.15.5 F. Hoffmann-La Roche Recent Developments
8.16 Kedrion Biopharma
8.16.1 Kedrion Biopharma Corporation Information
8.16.2 Kedrion Biopharma - Celiac Disease Drug Product Portfolio and Specification
8.16.3 Kedrion Biopharma Performance Analysis (2021-2026)
8.16.4 Kedrion Biopharma Business and Markets Served
8.16.5 Kedrion Biopharma Recent Developments
8.17 Celgene
8.17.1 Celgene Corporation Information
8.17.2 Celgene - Celiac Disease Drug Product Portfolio and Specification
8.17.3 Celgene Performance Analysis (2021-2026)
8.17.4 Celgene Business and Markets Served
8.17.5 Celgene Recent Developments
9 Global Celiac Disease Drug Market Forecast by Product Type and End User (2026-2034)
9.1 Global Celiac Disease Drug Market Forecast by Product Type (2026-2034)
9.1.1 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Distension (2026-2034)
9.1.2 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Diarrhea (2026-2034)
9.1.3 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Anorexia (2026-2034)
9.1.4 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Celiac Disease Drug Market Forecast by End User (2026-2034)
9.2.1 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of First Line of Treatment (2026-2034)
9.2.2 Global Celiac Disease Drug Sales Volume, Revenue Forecast and Growth Rate of Second Line of Treatment (2026-2034)
10 Global Celiac Disease Drug Market Forecast by Geographic Region (2026-2034)
10.1 Global Celiac Disease Drug Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Celiac Disease Drug Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Our Clients
